Form 144 | BillionToOne(BLLN.US) Officer Proposes to Sell 3.87 Million in Common StocksMarket news · 18 Sep 2026
BillionToOne(BLLN.US) Officer Sells US$3.03 Million in Common StockMarket news · 17 Sep 2026
Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)TipRanks · 7 Aug 2026
William Blair Initiates BillionToOne(BLLN.US) With Buy RatingMarket news · 7 Aug 2026
Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL)TipRanks · 6 Aug 2026
BTIG Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $142Market news · 23 Jul 2026
J.P. Morgan Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $145Market news · 22 Jul 2026
Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $125Market news · 29 Jun 2026
Analysts Have Conflicting Sentiments on These Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Bio-Techne (TECH)TipRanks · 7 May 2026
Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN), ACADIA Pharmaceuticals (ACAD) and Revolution Medicines (RVMD)TipRanks · 7 May 2026
Piper Sandler Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $130Market news · 7 May 2026
A Quick Look at Today's Ratings for BillionToOne(BLLN.US), With a Forecast Between $100 to $145Market news · 7 May 2026
Stifel Nicolaus Keeps Their Buy Rating on BillionToOne, Inc. Class A (BLLN)TipRanks · 7 May 2026
Discussion
No comments yet — be the first to weigh in on BLLN.
No comments yet — be the first to weigh in on BLLN.